# A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma

> **NCT01591135** · PHASE3 · COMPLETED · sponsor: **Fudan University** · enrollment: 436 (actual)

## Conditions studied

- Esophageal Squamous Cell Carcinoma

## Interventions

- **DRUG:** Paclitaxel plus 5-fluorouracil
- **DRUG:** Cisplatin plus 5-fluorouracil
- **RADIATION:** Radiation therapy
- **RADIATION:** Radiation therapy

## Key facts

- **NCT ID:** NCT01591135
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 436 (ACTUAL)
- **Last updated:** 2018-10-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01591135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01591135, "A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01591135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*